Company Filing History:
Years Active: 1976-1977
Title: The Innovations of Peter Quitt
Introduction
Peter Quitt is a notable inventor based in Fullinsdorf, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotic compounds. With a total of 3 patents to his name, Quitt's work has had a meaningful impact on medical science.
Latest Patents
Among his latest patents, Quitt has developed water-soluble amoxicillin salts, specifically choline and N-methyl-D-glucamine salts of amoxicillin. These patents disclose processes for their preparation and pharmaceutical compositions that contain these salts as the active antibacterial component. Another significant patent involves 6-acyl derivatives of aminopenicillanic acid. This patent describes compounds represented by a specific formula, where A is a substituted or unsubstituted heterocyclic radical, and T is a C2-C5 alkyl, alkenyl, cyclopropylmethyl, cyclobutylmethyl, or cyclopentyl group. The process for their preparation and novel intermediates are also disclosed, highlighting their usefulness as antibiotics.
Career Highlights
Peter Quitt is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at this esteemed organization has allowed him to focus on innovative solutions in antibiotic development.
Collaborations
Quitt has collaborated with notable colleagues such as Andre Furlenmeier and Karl Vogler. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Peter Quitt's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to influence the development of effective antibiotic treatments.